RAYFORMA Trademark

Trademark Overview

On Tuesday, February 7, 2023, a trademark application was filed for RAYFORMA with the United States Patent and Trademark Office. The USPTO has given the RAYFORMA trademark a serial number of 97783859. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 16, 2025. This trademark is owned by JMPPD, LLC. The RAYFORMA trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, intraoral devices to chill ipsilateral nerves for the treatment of migraine
rayforma

General Information

Serial Number97783859
Word MarkRAYFORMA
Filing DateTuesday, February 7, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, January 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkRAY FORMA
Goods and ServicesMedical devices, namely, intraoral devices to chill ipsilateral nerves for the treatment of migraine

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, February 26, 2023
Primary Code010
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

Trademark Owner History

Party NameJMPPD, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNEW CITY, NY 10956

Trademark Events

Event DateEvent Description
Monday, December 11, 2023NON-FINAL ACTION E-MAILED
Sunday, February 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 5, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023NON-FINAL ACTION WRITTEN
Monday, December 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 10, 2024ASSIGNED TO LIE
Monday, August 19, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, December 11, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, December 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2024PETITION TO REVIVE-GRANTED
Wednesday, December 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 19, 2024NON-FINAL ACTION WRITTEN
Thursday, January 16, 2025NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025NON-FINAL ACTION WRITTEN

Related Keywords

rayforma devices nerves treatment migraine ipsilateral chill namely intraoral medical